# Esomeprazole Magnesium Dihydrate 40 mg Tablets Relative to Nexium 40 mg Tablets Under Fasting Condition

> **NCT06233097** · PHASE1 · UNKNOWN · sponsor: **Bio-innova Co., Ltd** · enrollment: 30 (estimated)

## Conditions studied

- Healthy Subjects

## Interventions

- **DRUG:** Esomeprazole magnesium dihydrate-Test product
- **DRUG:** Esomeprazole magnesium dihydrate-Reference product

## Key facts

- **NCT ID:** NCT06233097
- **Lead sponsor:** Bio-innova Co., Ltd
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2024-08-29
- **Primary completion:** 2024-09-28
- **Final completion:** 2024-10-12
- **Target enrollment:** 30 (ESTIMATED)
- **Last updated:** 2024-01-31


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06233097

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06233097, "Esomeprazole Magnesium Dihydrate 40 mg Tablets Relative to Nexium 40 mg Tablets Under Fasting Condition". Retrieved via AI Analytics 2026-06-23 from https://api.ai-analytics.org/clinical/NCT06233097. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*